Brian Skorney
Stock Analyst at Robert W. Baird
Total Price Targets
34
Stocks Covered
17
Sectors
Healthcare
Most Recent
Feb 10, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Brian Skorney
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| RGNX | REGENXBIO Inc. | $27.00 | $9.14 | +195.4% | 1 | Feb 10, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc. | $742.00 | $703.72 | +5.4% | 3 | Feb 2, 2026 |
| MIRM | Mirum Pharmaceuticals, Inc. | $88.00 | $97.47 | -9.7% | 3 | Dec 8, 2025 |
| DYN | Dyne Therapeutics, Inc. | $30.00 | $17.50 | +71.4% | 1 | Dec 8, 2025 |
| BHVN | Biohaven Ltd. | $42.00 | $9.71 | +332.5% | 3 | Nov 5, 2025 |
| SRPT | Sarepta Therapeutics, Inc. | $15.00 | $21.60 | -30.6% | 4 | Nov 4, 2025 |
| GILD | Gilead Sciences, Inc. | $108.00 | $132.04 | -18.2% | 3 | Aug 8, 2025 |
| SLNO | Soleno Therapeutics, Inc. | $121.00 | $52.86 | +128.9% | 2 | Jul 11, 2025 |
| BIIB | Biogen Inc. | $300.00 | $186.69 | +60.7% | 4 | Nov 15, 2024 |
| ALMS | Alumis Inc. Common Stock | $25.00 | $25.27 | -1.1% | 1 | Oct 30, 2024 |
| ANRO | Alto Neuroscience, Inc. | $10.00 | $24.73 | -59.6% | 2 | Oct 23, 2024 |
| AMGN | Amgen Inc. | $215.00 | $328.69 | -34.6% | 1 | Sep 25, 2024 |
| NRIX | Nurix Therapeutics, Inc. | $26.00 | $16.83 | +54.5% | 1 | Sep 5, 2024 |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $28.00 | $5.82 | +381.1% | 1 | Jun 12, 2024 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $62.00 | $38.93 | +59.3% | 1 | May 23, 2024 |
| NBIX | Neurocrine Biosciences, Inc. | $150.00 | $131.64 | +13.9% | 2 | Nov 2, 2022 |
| VRTX | Vertex Pharmaceuticals Incorporated | $240.00 | $425.06 | -43.5% | 1 | Mar 22, 2022 |
Recent Activity
- Feb 10, 2026— Set$27.00price target onRGNX(REGENXBIO Inc.)
- Feb 2, 2026— Set$742.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Dec 8, 2025— Set$30.00price target onDYN(Dyne Therapeutics, Inc.)
- Dec 8, 2025— Set$88.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
- Nov 5, 2025— Set$42.00price target onBHVN(Biohaven Ltd.)
- Nov 4, 2025— Set$15.00price target onSRPT(Sarepta Therapeutics, Inc.)
- Oct 29, 2025— Set$630.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Aug 8, 2025— Set$108.00price target onGILD(Gilead Sciences, Inc.)
- Jul 11, 2025— Set$121.00price target onSLNO(Soleno Therapeutics, Inc.)
- Nov 15, 2024— Set$300.00price target onBIIB(Biogen Inc.)
- Nov 7, 2024— Set$193.00price target onSRPT(Sarepta Therapeutics, Inc.)
- Oct 30, 2024— Set$25.00price target onALMS(Alumis Inc. Common Stock)
- Oct 23, 2024— Set$10.00price target onANRO(Alto Neuroscience, Inc.)
- Sep 25, 2024— Set$215.00price target onAMGN(Amgen Inc.)
- Sep 24, 2024— Set$940.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Sep 23, 2024— Set$60.00price target onBHVN(Biohaven Ltd.)
- Sep 5, 2024— Set$26.00price target onNRIX(Nurix Therapeutics, Inc.)
- Aug 8, 2024— Set$44.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
- Jul 29, 2024— Set$294.00price target onBIIB(Biogen Inc.)
- Jun 21, 2024— Set$200.00price target onSRPT(Sarepta Therapeutics, Inc.)
Frequently Asked Questions
Who is Brian Skorney?
Brian Skorney is a stock analyst at Robert W. Baird covering 17 stocks primarily in Healthcare. They have issued 34 price targets since Feb 11, 2022.
What stocks does Brian Skorney cover?
Brian Skorney currently covers 17 stocks, including SRPT, BIIB, REGN, MIRM, BHVN.
What is Brian Skorney's latest price target?
Brian Skorney's most recent price target was $27.00 on RGNX (REGENXBIO Inc.), set on Feb 10, 2026.
What is Brian Skorney's highest price target?
Brian Skorney's highest issued price target is $940.00 on REGN, set on Sep 24, 2024.
More Analysts at Robert W. Baird
Coverage based on publicly published price targets. Not investment advice.